Chirehwa MT, Resendiz-Galvan JE, Court R, De Kock M, et al. Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling. Antimicrob Agents Chemother 2023 Feb 6:e0142622. doi: 10.1128/aac.01426.
PMID: 36744891